Leo Schouten

Dr. Leo Schouten

Department of Epidemiology, Faculty of Health, Medicine and Life Sciences, Maastricht University, The Netherlands
orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2002 in Cancer
Verified
Journal Article
Closed access
PDF file
Leo SchoutenLeo Schouten
Leo Schouten
JRJoost Rutten
Joost Rutten
HHHans A. M. Huveneers
Hans A. M. Huveneers
ATAlbert Twijnstra
Albert Twijnstra

10 July 2013 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
VSVeronica Wendy Setiawan
Veronica Wendy Setiawan
HYHannah P. Yang
Hannah P. Yang
MPMalcolm C. Pike
Malcolm C. Pike
SMSusan E. McCann
Susan E. McCann
HYHerbert Yu
Herbert Yu
PHPamela L. Horn-Ross
Pamela L. Horn-Ross
Purpose: Endometrial cancers have long been divided into estrogen-dependent type I and the less common clinically aggressive estrogen-independent type II. Little is known about risk factors for type II tumors because most studies lack sufficient cases to study these much less common tumors separately. We examined whether so-called classical endometrial cancer risk factors also influence the risk of type II tumors. Patients and Methods: Individual-level data from 10 cohort and 14 case-control studies from the Epidemiology of Endometrial Cancer Consortium were pooled. A total of 14,069 endometrial cancer cases and 35,312 controls were included. We classified endometrioid (n = 7,246), adenocarcinoma not otherwise specified (n = 4,830), and adenocarcinoma with squamous differentiation (n = 777) as type I tumors and serous (n = 508) and mixed cell (n = 346) as type II tumors. Results: Parity, oral contraceptive use, cigarette smoking, age at menarche, and diabetes were associated with type I and type II tumors to similar extents. Body mass index, however, had a greater effect on type I tumors than on type II tumors: odds ratio (OR) per 2 kg/m2 increase was 1.20 (95% CI, 1.19 to 1.21) for type I and 1.12 (95% CI, 1.09 to 1.14) for type II tumors (Pheterogeneity < .0001). Risk factor patterns for high-grade endometrioid tumors and type II tumors were similar. Conclusion: The results of this pooled analysis suggest that the two endometrial cancer types share many common etiologic factors. The etiology of type II tumors may, therefore, not be completely estrogen independent, as previously believed.

1 February 2008 in Environmental Health Perspectives
Verified
Journal Article
Open access
RBRob Beelen
Rob Beelen
GHGerard Hoek
Gerard Hoek
PBPiet A. van Den Brandt
Piet A. van Den Brandt
RGR. Alexandra Goldbohm
R. Alexandra Goldbohm
PFPaul Fischer
Paul Fischer
BBBert Brunekreef
Bert Brunekreef
BackgroundSeveral studies have found an effect on mortality of between-city contrasts in long-term exposure to air pollution. The effect of within-city contrasts is still poorly understood.ObjectivesWe studied the association between long-term exposure to traffic-related air pollution and mortality in a Dutch cohort.MethodsWe used data from an ongoing cohort study on diet and cancer with 120,852 subjects who were followed from 1987 to 1996. Exposure to black smoke (BS), nitrogen dioxide, sulfur dioxide, and particulate matter ≤mu;M2.5), as well as various exposure variables related to traffic, were estimated at the home address. We conducted Cox analyses in the full cohort adjusting for age, sex, smoking, and area-level socioeconomic status.ResultsTraffic intensity on the nearest road was independently associated with mortality. Relative risks (95% confidence intervals) for a 10-μg/m3 increase in BS concentrations (difference between 5th and 95th percentile) were 1.05 (1.00–1.11) for natural cause, 1.04 (...

20 August 2016 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
NWNicolas Wentzensen
Nicolas Wentzensen
EPElizabeth M. Poole
Elizabeth M. Poole
BTBritton Trabert
Britton Trabert
EWEmily White
Emily White
AAAlan A. Arslan
Alan A. Arslan
STShelley S. Tworoger
Shelley S. Tworoger
Purpose: An understanding of the etiologic heterogeneity of ovarian cancer is important for improving prevention, early detection, and therapeutic approaches. We evaluated 14 hormonal, reproductive, and lifestyle factors by histologic subtype in the Ovarian Cancer Cohort Consortium (OC3). Patients and Methods: Among 1.3 million women from 21 studies, 5,584 invasive epithelial ovarian cancers were identified (3,378 serous, 606 endometrioid, 331 mucinous, 269 clear cell, 1,000 other). By using competing-risks Cox proportional hazards regression stratified by study and birth year and adjusted for age, parity, and oral contraceptive use, we assessed associations for all invasive cancers by histology. Heterogeneity was evaluated by likelihood ratio test. Results: Most risk factors exhibited significant heterogeneity by histology. Higher parity was most strongly associated with endometrioid (relative risk [RR] per birth, 0.78; 95% CI, 0.74 to 0.83) and clear cell (RR, 0.68; 95% CI, 0.61 to 0.76) carcinomas (P value for heterogeneity [P-het] < .001). Similarly, age at menopause, endometriosis, and tubal ligation were only associated with endometrioid and clear cell tumors (P-het ≤ .01). Family history of breast cancer (P-het = .008) had modest heterogeneity. Smoking was associated with an increased risk of mucinous (RR per 20 pack-years, 1.26; 95% CI, 1.08 to 1.46) but a decreased risk of clear cell (RR, 0.72; 95% CI, 0.55 to 0.94) tumors (P-het = .004). Unsupervised clustering by risk factors separated endometrioid, clear cell, and low-grade serous carcinomas from high-grade serous and mucinous carcinomas. Conclusion: The heterogeneous associations of risk factors with ovarian cancer subtypes emphasize the importance of conducting etiologic studies by ovarian cancer subtypes. Most established risk factors were more strongly associated with nonserous carcinomas, which demonstrate challenges for risk prediction of serous cancers, the most fatal subtype.

1 February 1994 in The Lancet
Verified
Journal Article
Closed access
FLF.E. van Leeuwen
F.E. van Leeuwen
ABA.W. van Den Belt-Dusebout
A.W. van Den Belt-Dusebout
JBJ. Benraadt
J. Benraadt
FDF.W. Diepenhorst
F.W. Diepenhorst
HTH. van Tinteren
H. van Tinteren
MBM. Bontenbal
M. Bontenbal

1 August 2000 in International Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
ABAnita Am Botterweck
Anita Am Botterweck
Leo SchoutenLeo Schouten
Leo Schouten
AVAlexander Volovics
Alexander Volovics
Elisabeth DorantElisabeth Dorant
Elisabeth Dorant
PBPiet A van Den Brandt
Piet A van Den Brandt
Background In many western countries an increase in incidence of adenocarcinoma of the oesophagus and/or gastric cardia have been reported. The aim of this study was to describe and compare trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in several areas of Europe, 1968–1995, using Eurocim (a database of cancer incidence and mortality data from 95 European cancer registries). Methods Time-trends in age-standardized incidence rates of adenocarcinomas of the oesophagus and gastric cardia are described in 11 population-based cancer registries from 10 countries in North, South, East, West and Central Europe, 1968–1995. The statistical significance of the time-trends in incidence was assessed using Poisson regression analysis. Results An increase in incidence of adenocarcinomas of the oesophagus and gastric cardia was observed in Northern Europe (Denmark), Southern Europe (Italy, Varese), Eastern Europe (Slovakia) and Western Europe (England and Wales, Scotland). In Central Europe (Switzerland, Basel) and in the cancer registries of Iceland (Northern Europe), France, Bas-Rhin and Calvados, Southern Ireland, and the Netherlands, Eindhoven (Western Europe) no rise in incidence was observed. The increase in incidence of adenocarcinomas of the oesophagus and gastric cardia was accompanied by a decrease in incidence of both adenocarcinomas and non-adenocarcinomas of the non-cardia part of the stomach in almost all of the 11 cancer registries studied. Increased histological verification of tumours of the oesophagus and stomach and improvement in precision of histological diagnosis may partly explain the increase in incidence of adenocarcinomas in some registries. Conclusions This study, using Eurocim data, supports the findings from other time-trend studies of population-based cancer registries in western countries.